Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma

BACKGROUND: Despite its toxicity, cisplatin every 3 weeks (q3w) is the standard potentiation of chemo-radiotherapy for head and neck squamous cell carcinoma. This study aimed to determine whether weekly cisplatin (q1w) could be a safe and effective alternative. PATIENTS AND METHODS: Two hundred and...

Descripción completa

Detalles Bibliográficos
Autores principales: Fayette, Jérôme, Molin, Yann, Lavergne, Emilie, Montbarbon, Xavier, Racadot, Séverine, Poupart, Marc, Ramade, Antoine, Zrounba, Philippe, Ceruse, Philippe, Pommier, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664534/
https://www.ncbi.nlm.nih.gov/pubmed/26648696
http://dx.doi.org/10.2147/DDDT.S81488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664534/
https://www.ncbi.nlm.nih.gov/pubmed/26648696
http://dx.doi.org/10.2147/DDDT.S81488

Ejemplares similares